These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Conjugated polysaccharide vaccines. Ahmad H; Chapnick EK Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795 [TBL] [Abstract][Full Text] [Related]
4. Immune responses to polysaccharides: lessons from humans and mice. González-Fernández A; Faro J; Fernández C Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186 [TBL] [Abstract][Full Text] [Related]
5. Bacterial polysaccharides as vaccines--immunity and chemical characterization. Lee CJ; Lee LH; Lu CS; Wu A Adv Exp Med Biol; 2001; 491():453-71. PubMed ID: 14533815 [TBL] [Abstract][Full Text] [Related]
6. [Emphasis on bacterial vaccines]. Huet M Arch Inst Pasteur Tunis; 1982 Dec; 59(4):481-93. PubMed ID: 6820928 [No Abstract] [Full Text] [Related]
7. New bacterial vaccines. Mäkelä PH Pediatr Infect Dis; 1982; 1(5):291-4. PubMed ID: 6818533 [No Abstract] [Full Text] [Related]
8. [Suppurative bacterial meningitis and the outlook for specific prevention]. Demina AA; Deviatkina NP Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):3-10. PubMed ID: 6429984 [No Abstract] [Full Text] [Related]
10. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report. Lepow ML; Gold R N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865 [No Abstract] [Full Text] [Related]
11. Bacterial capsular polysaccharides--biochemistry, immunity and vaccine. Lee CJ Mol Immunol; 1987 Oct; 24(10):1005-19. PubMed ID: 3119993 [TBL] [Abstract][Full Text] [Related]
12. Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children. Eskola J; Käyhty H; Takala A; Rönnberg PR; Kela E; Peltola H Vaccine; 1990 Apr; 8(2):107-10. PubMed ID: 2110703 [TBL] [Abstract][Full Text] [Related]
13. Capsulate bacteria and the lung. Buttery J; Moxon ER Br Med Bull; 2002; 61():63-80. PubMed ID: 11997299 [TBL] [Abstract][Full Text] [Related]
14. [Immunological principles of polysaccharide-protein conjugate vaccination]. Meyer M; Gahr M Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396 [TBL] [Abstract][Full Text] [Related]
15. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Wong VK; Quagliata R; Adler R; Kim KS Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604 [TBL] [Abstract][Full Text] [Related]
16. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination. Wong VK; Kim KS Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847 [No Abstract] [Full Text] [Related]